USA Pharma News | Healthcare News 3/5

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

ipharmaservices

Sep 26, 2020

Pfizer received the approval of Xalkori for ALK-positive anaplastic large cell lymphoma

ipharmaservices

Sep 24, 2020

FDA approved Trelegy Ellipta for asthma, GSK’s triple therapy is now available for asthma and COPD

ipharmaservices

Sep 10, 2020

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

ipharmaservices

Sep 9, 2020

FDA extended emergency use authorization of Veklury to all hospitalized patients

ipharmaservices

Aug 30, 2020

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

ipharmaservices

Aug 27, 2020

FDA issued Emergency Use Authorization of Convalescent Plasma for COVID-19 treatment

ipharmaservices

Aug 25, 2020

Johnson and Johnson acquired Momenta Pharmaceuticals, aims to strength immunology profile

ipharmaservices

Aug 23, 2020

Amgen’s Kyprolis and Janssen’s Darzalex combination approved by the US FDA for multiple myeloma

ipharmaservices

Aug 22, 2020

Novartis Kesimpta approved for relapsing multiple sclerosis in the US

ipharmaservices

Aug 21, 2020

FDA says no to Gilead’s most anticipated product filgotinib

ipharmaservices

Aug 19, 2020

Genentech’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder in the US

ipharmaservices

Aug 15, 2020

Gilead submitted NDA for Veklury to treat COVID-19 in the US

ipharmaservices

Aug 13, 2020

FDA approved Genentech’s Evrysdi for Spinal Muscular Atrophy

ipharmaservices

Aug 8, 2020

NOVARTIS COSENTYX APPROVED IN EUROPE FOR PAEDIATRIC PSORIASIS

ipharmaservices

Aug 8, 2020

GSK’s first anti-BCMA therapy Blenrep was approved in the US

ipharmaservices

Aug 6, 2020

Gilead’s CAR-T cell therapy approved for Relapsed or Refractory Mantle Cell Lymphoma

ipharmaservices

Jul 25, 2020

The US FDA approved Janssen’s psoriasis blockbuster for Psoriatic Arthritis

ipharmaservices

Jul 17, 2020

UNITED STATES HEALTHCARE SYSTEM

ipharmaservices

Jul 4, 2020

US FDA approved Rukobia (fostemsavir) for HIV patients who have limited treatment options

ipharmaservices

Jul 3, 2020

iPharmaCenter

ipharmacenter Consulting services

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

Pfizer received the approval of Xalkori for ALK-positive anaplastic large cell lymphoma

FDA approved Trelegy Ellipta for asthma, GSK’s triple therapy is now available for asthma and COPD

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

FDA extended emergency use authorization of Veklury to all hospitalized patients

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

FDA issued Emergency Use Authorization of Convalescent Plasma for COVID-19 treatment

Johnson and Johnson acquired Momenta Pharmaceuticals, aims to strength immunology profile

Amgen’s Kyprolis and Janssen’s Darzalex combination approved by the US FDA for multiple myeloma

Novartis Kesimpta approved for relapsing multiple sclerosis in the US

FDA says no to Gilead’s most anticipated product filgotinib

Genentech’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder in the US

Gilead submitted NDA for Veklury to treat COVID-19 in the US

FDA approved Genentech’s Evrysdi for Spinal Muscular Atrophy

NOVARTIS COSENTYX APPROVED IN EUROPE FOR PAEDIATRIC PSORIASIS

GSK’s first anti-BCMA therapy Blenrep was approved in the US

Gilead’s CAR-T cell therapy approved for Relapsed or Refractory Mantle Cell Lymphoma

The US FDA approved Janssen’s psoriasis blockbuster for Psoriatic Arthritis

UNITED STATES HEALTHCARE SYSTEM

US FDA approved Rukobia (fostemsavir) for HIV patients who have limited treatment options